| Age/Sex |
Site |
type |
TNM |
Hist. |
Nod. |
Ope |
Hepa. |
Chemtherapy |
Prog.(M) |
| 60/M |
LD |
3 |
T4bN2 |
pap |
2 |
D. D2 Colon |
+ |
CDDP+5-FU*, PR |
19D. H.,bone |
| 66/M |
M |
2 |
T3N2 |
por1 |
3 |
D. D2 |
+ |
CDDP+5-FU/5-FU |
43D. H. |
| 63/M |
UE |
3 |
T4aN1 |
por2 |
1 |
T+SD2 |
- |
5-FU, PD |
13D. H. |
| 54/M |
UE |
2 |
T4bN0 |
tub1 |
1 |
T. D3 |
+ |
MMC,5-FU+CDDP/UFT, S-1 |
32D. H.,L. |
| 61/M |
L |
2 |
T4aN1 |
tub1 |
2 |
D. D2 |
- |
CDDP/S-1,5’-DFUR, SD |
32D.H.N. |
| 75/M |
LMU |
3 |
T4bN2 |
tub1 |
≥ 4 |
D. D1 |
- |
CDDP/5’-DFUR,PSK,CR |
67A. |
| 72/M |
LMU |
5 |
T4aN3b |
tub1 |
≥ 4 |
T. D1 |
- |
CDDP/S-1**, PR |
44D. H. |
| 67/M |
UE |
2 |
T4aN2 |
tub1 |
3 |
T, D1 |
- |
CDDP/S-1, PR |
33DN,bone |
| 66/M |
ML |
2 |
T4aN3a |
tub1 |
≥ 4 |
D.D1 |
- |
CDDP/S-1, SD |
26D. H. |
| 64/M |
U |
1 |
T4aN3a M1LYM |
por1 |
≥ 4 |
T+S,D1 |
- |
CDDP/S-1, SD |
12D. H. |
| 56/M |
LD |
3 |
T4aN3b M1LYM |
tub1 |
≥ 4 |
D. D1 |
- |
CDDP/S-1, SD |
8D. H. |
| 77/F |
LMU |
3 |
T4aN3b P1M1LY |
tub2 |
≥ 4 |
D. D0 |
- |
CDDP/S-1, PR CDDP/CPT-11 |
19D. |
| 71/M |
U |
3 |
T4aN3b |
por1 |
2 |
T+S,D2 |
- |
CDDP/S-1, SD |
10D. H. |
| 65/M |
U |
2 |
T4aN2 |
tub2 |
≥ 4 |
T, D2 |
- |
CDDP/S-1,PR, S-1+TXL, S-1+CDDP+TXL |
19D. L. |
| 65/M |
UM |
3 |
T4aN3a |
por1 |
2 |
T, D1 |
- |
pre.S-1+CDDP(4 c. PD) CDDP/S-1 PD |
6D. N.,H. |
| 65/M |
LM |
3 |
T4aN3b |
por1 |
≥ 4 |
D,D2 |
- |
pre.S-1+TXL(5c. PR) CDDP+MMC/S-1 PD |
3D. N.,H. |
| 68/M |
LD |
1 |
T4aN0 |
tub2 |
2 |
D, D2 |
- |
CDDP/S-1,5’-DFUR, PR |
38D. |
M male, F female, L lower third portion, M middle third portion, U upper third portion, T depth of tumor invasion, N lymph node metastasis, M distant metastasis, M1LYM
distant lymph node metastasis, P peritoneal metastasis, Hist histology, pap papillary adenocarcinoma, por1 poorly differentiated adenocarcinoma solid type, por2 poorly
differentiated adenocarcinoma non-solid type, tub1 tubular adeno carcinoma well-differentiated, tub2 tubular adenocarcinoma moderately differentiated, Nod the number of
metastatic nodule, Ope operation, D distal gastrectomy, T total gastrectomy, S splenectomy, Hepa hepatectomy, pre preoperative chemotherapy, c cycle, Prog prognosis,
M month, D dead, A alive, H recurrence in the liver, L recurrence in the lung, N recurrence in the lymph node, *patient underwent hepatectomy after HAI, **patient underwent
coagulation after surgery |
